California Marijuana

GRAND JUNCTION, Colo. —  EcoGen Biosciences (“EcoGen” or the “Company”), a leading manufacturer and supplier of hemp-derived specialty ingredients, proprietary formulations, and private-label finished products in the United States, announced today that the Company is rebranding its Brazilian CannaMeds brand of cannabidiol (CBD) products as EcoGen Brasil, to bring world class quality CBD to the market, with the confidence of physicians. EcoGen Brasil, a wholly owned subsidiary of Kadenwood, will continue to offer products with the same potency, efficacy, and quality as CannaMeds while bringing new formulations and innovations to the market. The CBD products will be prescribed by local Brazilian medical doctors. “Brazilian doctors and patients are looking for safe, consistent and high-quality CBD products as a solution to health and wellness,” said Cassio Ismael, EcoGen Brasil Head of Sales. “We have loyal consumers who trust their doctors to prescribe CBD products and are pr...

LOS ANGELES — Global Garden announces its partnership with AB Lighting as a distributor of their LED grow lights. Although the AB Lighting brand is new, the team is not. They are the manufacturer of one of the largest LED grow light series that is distributed in North America. With over 30 years of research and development, 50+ tested spectra, 100+ tested crops, and 30+ fixture industrial designs, they have the skills to design best-in-class fixtures. One way AB Lighting sets itself apart from the competition is their impressive heat sinks. Since heat is the enemy of LEDs, they have created a unique and patented heat sink that allows the fixtures to remain very cool to the touch after a full day’s operation. Cool operation extends the life of the grow light. AB Lighting has fixtures for all stages of plant growth. Their offerings include: AB520 – is a veg light that has a higher percentage of blue light to keep the plants compact and encourage branching. It was specifically des...

While cannabis may still have some distance to go before it’s truly normalized, the plant and related products are no longer exactly taboo. This shift is apparent in increasingly blatant pop-culture references, expanding legalization efforts, and the new, unabashed ways products are marketed to the masses—most notably by celebrities. A race to dominate the market in the same way Nike owns athletic shoes and Coca-Cola eclipses all other soft drinks has contributed to product saturation and fierce competition in the cannabis space. Much as Nike and Coke did decades ago, cannabis brands increasingly seek celebrity involvement to bolster their image and create emotional links with consumers. No matter the industry or product, a celebrity’s endorsement—or better yet, ownership stake—can precipitate earned media and consumer interest in the short term. Played right, the hype can become brand awareness that sticks around for the long haul. Cannabis is becoming a lifestyle product that ties...

It may be clichéd to say time flies when you’re having fun, but it is an apt statement when you’re working in an industry like cannabis. With each passing day, the industry grows broader and more robust around the world, but particularly in the United States and Canada. Last fall, the District of Columbia eliminated barriers that prevented many citizens from accessing medical marijuana cards. More recently, residents in Maryland and Missouri voted to legalize recreational use. Amid these exciting changes, one thing has remained consistent: the growing popularity of edibles. Decades ago, the average patient or recreational consumer likely thought of edibles as brownies. Today, the medicinal and recreational benefits of cannabis can be enjoyed in a variety of form factors, including mints, sweeteners, gum, and a broad spectrum of other products. Since we haven’t examined the category in depth for more than a year, now might be a good time to take another look. If there’s one word to de...

Insync Shop Fittings provide retailers and designers the flexibility to create spaces that are exciting for the shopper, make product exploration fun, and brand engagement more meaningful. Our award-winning solution uses versatile, electrified standards that carry a low-voltage DC current to power a wide range of plug and play accessories that mount directly into the electrified standards, without wires! Built-in LED lights ensure merchandise and displays are evenly lit. Insync makes it extremely simple to play promotional messages, product information, tutorials, video content, and more by adding IoT solutions like digital screens, endless aisles, and RFID compatibilities; all of which can be mounted anywhere along the vertical standards and powered instantly. Standards are available in recessed, wall-mount, or floor-to-ceiling options and can be incorporated into existing spaces or designed from scratch. Choose from custom finishes and millwork to create a space that reflects your...

TALLAHASSEE, Fla. — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the closing of a commercial loan secured by a cultivation and manufacturing facility located in West Virginia for aggregate gross proceeds of $18.9 million. Trulieve will pay interest at a fixed rate of 7.3% for the first five years of the ten-year loan. After five years, the rate resets at five-year Treasury plus 3.5% for the remainder of the loan. The Company may prepay the loan with cash from operations with no prepayment penalties at any time. The Company intends to use the net loan proceeds for general corporate purposes. “We are pleased to announce our second non-dilutive financing this month,” said Trulieve Chief Executive Officer, Kim Rivers. “This financing at attractive terms further bolsters our cash position as we enter 2023.” About Trulieve Trulieve is an industry leading, ver...

BARRIE, ON – MediPharm Labs Corp. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) and VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO”) today announced that MediPharm and VIVO have entered into a definitive arrangement agreement (the “Arrangement Agreement”) whereby MediPharm has agreed to acquire VIVO in an all-equity business combination transaction (the “Transaction”). The Transaction is expected to combine two highly complementary businesses, creating a unique and market differentiating international medical cannabis leader. Upon the completion of the Transaction, existing MediPharm shareholders are expected to own between 65% and 79% of the combined company resulting from the Transaction (the “Combined Company”) and VIVO shareholders are expected to own between 35% and 21% of the Combined Company. Under the terms of the Arrangement Agreement, holders of common shares of VIVO (“VIVO Shares”) will receive between 0.2110 and 0.4267 com...